Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel resolution process for high-purity beraprost acid via diastereomeric esterification. Reduces manufacturing costs and ensures supply chain stability for pharmaceutical intermediates.
Discover the advanced synthesis of 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid via patent CN1629154A, offering cost-effective and high-purity pharmaceutical intermediates.
Advanced synthesis of optically active 1-amino-2-vinylcyclopropane carboxylic acid esters via chiral resolution. Reliable pharmaceutical intermediate supplier offering cost-effective antiviral API precursors.
Patent CN119504564A details high-yield chiral synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediates globally.
Novel synthesis of antiviral entecavir using naphthyl silane protection. Reduces cost and improves scalability for pharmaceutical manufacturing.
Discover the patented CN101928214B method for synthesizing dexketoprofen trometamol. This report analyzes cost-effective octylglucamine resolution and industrial scalability for API manufacturers.
Advanced resolution process for homocysteine-gamma-thiolactone via chiral acids and aldehyde catalysis. Delivers superior yields and cost efficiency for pharmaceutical intermediates.
Patent CN1644012A reveals enzymatic resolution for diltiazem precursor. Offers high optical purity and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Explore the patented CN1293041C method for producing high-purity L-Phenylglycine. Discover cost-effective, low-waste manufacturing strategies for reliable pharmaceutical intermediate supply chains.
Patent CN104531794B reveals enzymatic route for high-purity chiral intermediate with scalable production capabilities and cost advantages.
Patent CN106496191B details a green enzymatic route for S-Pantoprazole Sodium, offering high purity and cost reduction for pharmaceutical supply chains.
Novel patent CN106008316A offers cost-effective Ledipasvir intermediate synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN1314336A details a novel two-component resolution method for high-purity (S)-(+)-ibuprofen, offering significant cost and time advantages for pharmaceutical manufacturing supply chains.
Discover a robust biocatalytic route for (2S, 3R)-methyl phenyl glycidate using Enterobacter sp. ECU 1107, offering superior purity and scalable manufacturing for taxol synthesis.
Patent CN101157950A details enzymatic resolution for optical pure selenium-methyl selenocysteine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel resolution method for optically pure ephedrine using L-(-)-dibenzoyltartaric acid. High yield, recoverable agent, scalable industrial process.
Patent CN110283036B details a novel column chromatography method for separating chiral diene ligands with 100% ee, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111518108B reveals a convergent 3-step synthesis for optically pure tetrandrine, offering superior yields and scalable production for pharmaceutical supply chains.
Patent CN119707758A reveals a low-cost synthesis route for chiral N-Boc homocysteine derivatives offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN103981248B enables high-purity leucine production. Cost-effective enzymatic process ensures supply chain reliability for pharma intermediates.